82.74

1.31% 1.07

Lantheus Holdings Inc (LNTH)

Overview News Price History Option Chain Financials Why LNTH Down? Discussions Forecast

Lantheus Holdings Inc stock is traded at $82.74, with a volume of 603.56K. It is up +1.31% in the last 24 hours and up +4.09% over the past month. Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Previous Close:

$81.67

Open:

$81.8

24h Volume:

603.56K

Relative Volume:

0.66

Market Cap:

$5.39B

Revenue:

$1.54B

Net Income/Loss:

$233.56M

P/E Ratio:

24.57

EPS:

3.3669

Net Cash Flow:

$348.64M

1W Performance:

+5.97%

1M Performance:

+4.09%

6M Performance:

+50.25%

1Y Performance:

-18.99%

1-Day Range:

$81.67

$83.94

1-Week Range:

$78.73

$83.94

52-Week Range:

$47.25

$108.91

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name

Lantheus Holdings Inc

Sector

Healthcare (1110)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

978 671-8001

Address

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Employee

1,193

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

LNTH's Discussions on Twitter

Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNTH Lantheus Holdings Inc	82.74	5.25B	1.54B	233.56M	348.64M	3.3669
TAK Takeda Pharmaceutical Co Adr	17.85	57.12B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	121.11	49.56B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.70	43.86B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.77	35.89B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	578.54	25.06B	3.18B	1.33B	1.04B	27.90

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-26	Upgrade	William Blair	Mkt Perform → Outperform
Dec-12-25	Upgrade	Truist	Hold → Buy
Oct-08-25	Downgrade	Goldman	Buy → Neutral
Aug-12-25	Downgrade	Truist	Buy → Hold
Dec-18-24	Initiated	Goldman	Buy
Sep-03-24	Initiated	Redburn Atlantic	Buy
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy
May-09-22	Initiated	B. Riley Securities	Buy
Apr-13-22	Initiated	Truist	Buy
Feb-01-21	Initiated	SVB Leerink	Outperform
Jun-29-20	Resumed	Jefferies	Buy
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform
Sep-23-16	Resumed	Credit Suisse	Neutral
Feb-24-16	Reiterated	RBC Capital Mkts	Outperform
Dec-11-15	Downgrade	Credit Suisse	Outperform → Neutral
Sep-30-15	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-20-15	Initiated	Credit Suisse	Outperform
Jul-20-15	Initiated	Jefferies	Buy
Jul-20-15	Initiated	RBC Capital Mkts	Outperform
Jul-20-15	Initiated	Robert W. Baird	Outperform
Jul-20-15	Initiated	Wells Fargo	Outperform

View All

Lantheus Holdings Inc Stock (LNTH) Latest News

Apr 13, 2026

What are the future prospects of Lantheus Holdings IncPortfolio Profit Report & Safe Entry Momentum Tips - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

How (LNTH) Movements Inform Risk Allocation Models - Stock Traders Daily

Apr 11, 2026

Apr 10, 2026

Lantheus Holdings Inc stock (US5156731020): Is its radiopharma dominance strong enough to unlock new - AD HOC NEWS

Apr 10, 2026

Bear Alert: Is Lantheus Holdings Inc exposed to political riskIPO Watch & Verified Momentum Stock Alerts - baoquankhu1.vn

Apr 10, 2026

A Look At Lantheus Holdings (LNTH) Valuation As Cautious Sentiment Follows Expected Sales And Margin Pressure - Yahoo Finance

Apr 10, 2026

Apr 08, 2026

Lantheus Holdings trying to close in on key technical measure - MSN

Apr 08, 2026

Apr 07, 2026

William Blair and Jefferies Maintain Outperform/Buy on Lantheus (LNTH) March 2026 - Meyka

Apr 07, 2026

Lantheus Holdings: Tensions From The PDUFA Extension (NASDAQ:LNTH) - Seeking Alpha

Apr 07, 2026

LNTH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 07, 2026

Apr 06, 2026

Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 48% Share Price Bounce - 富途牛牛

Apr 06, 2026

Apr 04, 2026

LANTHEUS HOLDINGS INC (1LNTH.MI) options chain - Yahoo Finance Australia

Apr 04, 2026

Apr 03, 2026